Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8 T Cell Receptors
Frontiers in Immunology, ISSN: 1664-3224, Vol: 11, Page: 248
2020
- 7Citations
- 29Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- CrossRef7
- Captures29
- Readers29
- 29
Article Description
T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a common, robust, and functionally potent mechanism that can trigger a spectrum of human immunopathologies associated with either transplant rejection, drug allergy, and autoimmunity. Here, we report that several virus-specific CD8 T cells directed against peptides derived from chronic viruses (EBV, CMV, and HIV-1) presented by high frequency HLA-A and -B allomorphs differentially cross-react toward HLA-B27 allotypes in a highly focused and hierarchical manner. Given the commonality of cross-reactive T cells and their potential contribution to adverse outcomes in allogeneic transplants, our study demonstrates that multiple antiviral T cells recognizing the same HLA allomorph could pose an extra layer of complexity for organ matching.
Bibliographic Details
10.3389/fimmu.2020.00248; 10.3389/fimmu.2020.00248.s001; 10.3389/fimmu.2020.00248.s003; 10.3389/fimmu.2020.00248.s002; 10.3389/fimmu.2020.00248.s004; 10.3389/fimmu.2020.00248.s005; 10.3389/fimmu.2020.00248.s006
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85081272248&origin=inward; http://dx.doi.org/10.3389/fimmu.2020.00248; http://www.ncbi.nlm.nih.gov/pubmed/32140156; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/supplementary-material/10.3389/fimmu.2020.00248.s001; http://dx.doi.org/10.3389/fimmu.2020.00248.s001; https://www.frontiersin.org/article/10.3389/fimmu.2020.00248/full; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/supplementary-material/10.3389/fimmu.2020.00248.s003; http://dx.doi.org/10.3389/fimmu.2020.00248.s003; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/supplementary-material/10.3389/fimmu.2020.00248.s002; http://dx.doi.org/10.3389/fimmu.2020.00248.s002; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/supplementary-material/10.3389/fimmu.2020.00248.s004; http://dx.doi.org/10.3389/fimmu.2020.00248.s004; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/supplementary-material/10.3389/fimmu.2020.00248.s005; http://dx.doi.org/10.3389/fimmu.2020.00248.s005; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/supplementary-material/10.3389/fimmu.2020.00248.s006; http://dx.doi.org/10.3389/fimmu.2020.00248.s006; https://dx.doi.org/10.3389/fimmu.2020.00248.s005; https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.00248/full; https://dx.doi.org/10.3389/fimmu.2020.00248.s006; https://dx.doi.org/10.3389/fimmu.2020.00248.s001; https://dx.doi.org/10.3389/fimmu.2020.00248; https://dx.doi.org/10.3389/fimmu.2020.00248.s003; https://www.frontiersin.org/articles/10.3389/fimmu.2020.00248/full; https://dx.doi.org/10.3389/fimmu.2020.00248.s002; https://dx.doi.org/10.3389/fimmu.2020.00248.s004; https://research-repository.uwa.edu.au/en/publications/preferential-hlab27-allorecognition-displayed-by-multiple-crossreactive-antiviral-cd8-t-cell-receptors(1958656a-cbd7-4487-ab75-d408f8109db8).html; https://research-repository.uwa.edu.au/en/publications/preferential-hla-b27-allorecognition-displayed-by-multiple-cross-
Frontiers Media SA
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know